BofA Lifts PepGen (PEPG) PT to $3 on Positive DM1 Data Despite Underperform Rating

By Yahoo! Finance   |   1 month ago
BofA Lifts PepGen (PEPG) PT to $3 on Positive DM1 Data Despite Underperform Rating

PepGen Inc. (NASDAQ:PEPG) shows promise with its DM1 program and positive Phase 1 data. BofA raised the price target to $3, noting the company's potential but also highlighting its developmental timeline and uncertainties.

Read More

Did you find this insightful?